---
category: news
title: "FDA head urges probe of agency’s dealings with Biogen, maker of controversial new Alzheimer’s drug"
excerpt: "FDA acting commissioner Janet Woodcock acknowledged in a letter to Christi Grimm, the acting inspector general of the Department of Health and Human Services, that there has been “significant ..."
publishedDateTime: 2021-07-10T00:30:00Z
originalUrl: "https://www.seattletimes.com/nation-world/fda-head-urges-probe-of-agencys-dealings-with-biogen-maker-of-controversial-new-alzheimers-drug/"
webUrl: "https://www.seattletimes.com/nation-world/fda-head-urges-probe-of-agencys-dealings-with-biogen-maker-of-controversial-new-alzheimers-drug/"
ampWebUrl: "https://www.seattletimes.com/nation-world/fda-head-urges-probe-of-agencys-dealings-with-biogen-maker-of-controversial-new-alzheimers-drug/?amp=1"
cdnAmpWebUrl: "https://www-seattletimes-com.cdn.ampproject.org/c/s/www.seattletimes.com/nation-world/fda-head-urges-probe-of-agencys-dealings-with-biogen-maker-of-controversial-new-alzheimers-drug/?amp=1"
type: article
quality: 10
heat: 10
published: false

provider:
  name: Seattle Times
  domain: seattletimes.com

topics:
  - Microsoft AI
  - AI

secured: "8VldVaXOQv6KzkporkwxI+jrQDu+whJpd8+30/DZWC0EWLZ3EJnPW0hKAmvXZ8u7Sja4V8ssziPx3K9YYGOwYX7i7tXuPHfpvXX7LJMWdOKHAGWIr4EtdSmP9AHeWhSnYLUp/stMIenKbOje3ocClvnWF7ea7eDkFl0jxzGCszE+B+HdRob2+PqXyddyMr9asH65OfnHnP6zRigsUJUPf8dx+XVcVrgFEodUrrvMUBTlfnLy0+8Lt28bTZ3F3K0NkP/C8golsm+wl2dWJgbPylhx7SqRb8C8PG3vwO1iVPHabr++juNprT7MrbNSLpqrjRbRizvJKqJ747CQ4QOu8U2GjtYinWoItxPbVjx8V60=;WQjLS7B1xn/oFqigO2ahDw=="
---

